Le cluster Analyse coût-bénéfice (MeSH) - Vaccins antigrippaux (économie)
| 000025 (2018) | Marjan J. Meijboom [Pays-Bas] ; Josien Riphagen-Dalhuisen [Pays-Bas] ; Eelko Hak [Pays-Bas] | The potential economic value of influenza vaccination for healthcare workers in The Netherlands. |
| 000181 (2012) | Anna K. Lugnér [Pays-Bas] ; Michiel Van Boven ; Robin De Vries ; Maarten J. Postma ; Jacco Wallinga | Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. |
| 000457 (1999) | M J Postma [Pays-Bas] ; J M Bos ; M. Van Gennep ; J C Jager ; R. Baltussen ; M J Sprenger | Economic evaluation of influenza vaccination. Assessment for The Netherlands. |
| 000023 (2018) | Miquel B. Ekkelenkamp ; C H Van Werkhoven ; Patricia C J. Bruijning-Verhagen ; Marc J M. Bonten | [A trial to study the effect of influenza vaccination in the elderly: ethical, feasible and badly needed]. |
| 000223 (2010) | Eelko Hak [Pays-Bas] ; Lisanne M. Knol ; Jan C. Wilschut ; Maarten J. Postma | [Influenza vaccination of hospital healthcare staff from the perspective of the employer: a positive balance]. |
| 000337 (2006) | E. Hak [Pays-Bas] ; M J Meijboom ; E. Buskens | Modelling the health-economic impact of the next influenza pandemic in The Netherlands. |
| 000417 (2003) | E. Hak [Pays-Bas] ; S. Van Loon ; E. Buskens ; G A Van Essen ; D. De Bakker ; M A J B. Tacken ; B A Van Hout ; D E Grobbee ; Th J M. Verheij | Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study. |
| 000463 (1998) | R M Baltussen [Pays-Bas] ; A. Reinders ; M J Sprenger ; M J Postma ; J C Jager ; A J Ament ; R M Leidl | Estimating influenza-related hospitalization in The Netherlands. |
| 000468 (1997) | E M Smit | [Cost-effectiveness of influenza vaccination in The Netherlands]. |
| 000469 (1997) | A. Reinders ; M J Postma ; T M Govaert ; M J Sprenger | [Cost-effectiveness of influenza vaccination The Netherlands]. |
| 000227 (2010) | Marcus Richard Keogh-Brown [Royaume-Uni] ; Richard D. Smith ; John W. Edmunds ; Philippe Beutels | The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands. |
| 000242 (2010) | Anna K. Lugnér [Pays-Bas] ; Sido D. Mylius ; Jacco Wallinga | Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. |
| 000264 (2009) | Anna K. Lugnér [Pays-Bas] ; Maarten J. Postma | Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs. |
| 000318 (2007) | Maarten J. Postma [Pays-Bas] ; Annoesjka Novak ; Huib W K F H. Scheijbeler ; Marlene Gyldmark ; Marianne L L. Van Genugten ; Jan C. Wilschut | Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands. |
| 000405 (2003) | Maarten J. Postma [Pays-Bas] ; Marie-Louise A. Heijnen ; Philippe Beutels ; Johannes C. Jager | Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands. |
| 000437 (2001) | M J Postma [Pays-Bas] ; M L Heijnen ; J C Jager | Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands. |
| 000462 (1998) | E. Hak [Pays-Bas] ; G A Van Essen ; E. Buskens ; W. Stalman ; R A De Melker | Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. |
| 000039 (2018) | Maartje S. Jacobs [Pays-Bas] ; Femke Kaasenbrood [Pays-Bas] ; Maarten J. Postma [Pays-Bas] ; Marinus Van Hulst [Pays-Bas] ; Robert G. Tieleman [Pays-Bas] | Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands. |
| 000121 (2014) | N. Longworth [Pays-Bas] ; M C M. Mourits ; H W Saatkamp | Economic analysis of HPAI control in the Netherlands II: comparison of control strategies. |
| 000122 (2014) | N. Longworth [Pays-Bas] ; M C M. Mourits ; H W Saatkamp | Economic analysis of HPAI control in the Netherlands I: epidemiological modelling to support economic analysis. |
| 000245 (2010) | Alies Van Lier [Pays-Bas] ; Albert Jan Van Hoek ; Wim Opstelten ; Hein J. Boot ; Hester E. De Melker | Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands. |
| 000299 (2007) | J C De Jong [Pays-Bas] | [New target populations for influenza vaccination; recommendations of the Health Council of the Netherlands]. |
| 000329 (2006) | M. Kretzschmar [Allemagne] ; J. Wallinga ; R A Coutinho | [Combating infectious disease using mathematical modelling]. |
| 000354 (2005) | Maarten J. Postma [Pays-Bas] ; Paul Jansema ; Huib W K F H. Scheijbeler ; Marianne L L. Van Genugten | Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults. |
| 000445 (2000) | E C Claas ; A C Kroes | [Critical review of anti-influenza drugs]. |
| 000552 (1976) | L R Verberne ; M H Mirck | [A practical horse and pony health programme. II. Prevention of parasitic and infectious disease (author's transl)]. |
| This area was generated with Dilib version V0.6.35. |  |